Latest Breaking News On - Bristol myers squibb breyanzi - Page 3 : comparemela.com

FDA Grants Priority Review to Expand Liso-Cel Indications in R/R Follicular Lymphoma and MCL

Liso-cel sBLAs for indications in relapsed/refractory FL and MCL after exposure to a BTK inhibitor have received priority review from the FDA.

United statesBristol myers squibb breyanziAnne kerberLate clinical developmentJapan ministry of healthBristol myers squibbInternational conference on malignant lymphomaInternational conferenceMalignant lymphomaPrescription drug user fee actCell therapyLisocabtagene maraleucelPriority reviewPhase 2 transcend fl study nct04245839 Phase 1 transcend nhl 001 study nct02631044

US FDA examined 22 cases of cancers in CAR-T probe -officials

By Michael Erman and Deena Beasley NEW YORK (Reuters) -The U.S. Food and Drug Administration has been looking into 22 cases of T-cell cancers that occurred .

United statesMax mamonkinPeter marksDeena beasleyStephen coatesNicole verdunBristol myers squibb breyanziDavid gregorioBaylor college of medicine centerDrug administrationMichael ermanNew england journalBaylor collegeBristol myers squibbLegend biotech

Health: US FDA examined 22 cases of cancers in CAR-T probe -officials

Health: US FDA examined 22 cases of cancers in CAR-T probe -officials
gdnonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gdnonline.com Daily Mail and Mail on Sunday newspapers.

United statesMax mamonkinBristol myers squibb breyanziPeter marksNicole verdunDrug administrationBaylor college of medicine centerNew england journalBaylor collegeBristol myers squibbLegend biotech

FDA's Peter Marks shares more on CAR-T secondary cancer probe

FDA's Peter Marks shares more on CAR-T secondary cancer probe
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Peter marksBristol myers squibb breyanziNicole verdunZachary robertsNovarti kymriahBiologics evaluationNew england journalGilead science tecartusBristol myers squibbLegend biotechAllogene therapeutics

Health: US FDA examined 22 cases of cancers in CAR-T probe -officials

United statesMax mamonkinBristol myers squibb breyanziPeter marksNicole verdunDrug administrationBaylor college of medicine centerNew england journalBaylor collegeBristol myers squibbLegend biotech